SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016844
Filing Date
2022-08-11
Accepted
2022-08-11 16:04:20
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glue-20220630.htm   iXBRL 10-Q 2180499
2 EX-31.1 glue-ex31_1.htm EX-31.1 20312
3 EX-31.2 glue-ex31_2.htm EX-31.2 20306
4 EX-32.1 glue-ex32_1.htm EX-32.1 19953
  Complete submission text file 0000950170-22-016844.txt   7227175

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glue-20220630_pre.xml EX-101.PRE 322138
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glue-20220630_def.xml EX-101.DEF 165747
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glue-20220630_lab.xml EX-101.LAB 411314
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glue-20220630.xsd EX-101.SCH 47567
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glue-20220630_cal.xml EX-101.CAL 40985
66 EXTRACTED XBRL INSTANCE DOCUMENT glue-20220630_htm.xml XML 1129365
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40522 | Film No.: 221155616
SIC: 2836 Biological Products, (No Diagnostic Substances)